These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25746551)

  • 1. Multimarker approach to risk stratification for long-term mortality in patients on chronic hemodialysis.
    Ishii J; Takahashi H; Kitagawa F; Kuno A; Okuyama R; Kawai H; Muramatsu T; Naruse H; Motoyama S; Matsui S; Hasegawa M; Aoyama T; Kamoi D; Kasuga H; Izawa H; Ozaki Y; Yuzawa Y
    Circ J; 2015; 79(3):656-63. PubMed ID: 25746551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications.
    Lurati Buse GA; Bolliger D; Seeberger E; Kasper J; Grapow M; Koller MT; Seeberger MD; Filipovic M
    Circulation; 2014 Sep; 130(12):948-57. PubMed ID: 25098242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients.
    Bargnoux AS; Morena M; Jaussent I; Maurice F; Chalabi L; Leray-Moragues H; Terrier N; Dupuy AM; Badiou S; Canaud B; Cristol JP
    Clin Chem Lab Med; 2013 Sep; 51(9):1865-74. PubMed ID: 23399590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department.
    Christ M; Laule K; Klima T; Hochholzer W; Breidthardt T; Perruchoud AP; Mueller C
    Int J Cardiol; 2008 May; 126(1):73-8. PubMed ID: 17481748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimarker approach with cystatin C, N-terminal pro-brain natriuretic peptide, C-reactive protein and red blood cell distribution width in risk stratification of patients with acute coronary syndromes.
    Vieira C; Nabais S; Ramos V; Braga C; Gaspar A; Azevedo P; Álvares Pereira M; Salomé N; Correia A
    Rev Port Cardiol; 2014 Mar; 33(3):127-36. PubMed ID: 24674467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.
    Brügger-Andersen T; Pönitz V; Staines H; Pritchard D; Grundt H; Nilsen DW
    BMC Cardiovasc Disord; 2008 Nov; 8():34. PubMed ID: 19032759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score.
    Eurlings LW; Sanders-van Wijk S; van Kimmenade R; Osinski A; van Helmond L; Vallinga M; Crijns HJ; van Dieijen-Visser MP; Brunner-La Rocca HP; Pinto YM
    J Am Coll Cardiol; 2012 Oct; 60(17):1668-77. PubMed ID: 23021334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
    Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
    Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
    Roubille F; Samri A; Cornillet L; Sportouch-Dukhan C; Davy JM; Raczka F; Gervasoni R; Pasquie JL; Cung TT; Piot C; Macia JC; Cransac F; Leclercq F
    Eur J Intern Med; 2010 Apr; 21(2):131-6. PubMed ID: 20206886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of biomarkers in heart failure: application of novel methods in the community.
    Dunlay SM; Gerber Y; Weston SA; Killian JM; Redfield MM; Roger VL
    Circ Heart Fail; 2009 Sep; 2(5):393-400. PubMed ID: 19808368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.
    Cabassi A; de Champlain J; Maggiore U; Parenti E; Coghi P; Vicini V; Tedeschi S; Cremaschi E; Binno S; Rocco R; Bonali S; Bianconcini M; Guerra C; Folesani G; Montanari A; Regolisti G; Fiaccadori E
    Int J Cardiol; 2013 Oct; 168(4):3334-9. PubMed ID: 23623341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate elevations of high-sensitivity cardiac troponin I and B-type natriuretic peptide in chronic hemodialysis patients are associated with mortality.
    Geerse DA; van Berkel M; Vogels S; Kooman JP; Konings CJ; Scharnhorst V
    Clin Chem Lab Med; 2013 Jun; 51(6):1321-8. PubMed ID: 23241607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.